Biofeedback in Cardiovascular Disease

Complementary and Integrative Therapies for Cardiovascular Disease

Volumn , Issue , 2005, Pages 135-150

  McGrady, Angele ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 22044433491     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03002-1.50011-2     Document Type: Chapter

References (66)

1. Schwartz M, Andrasik F Biofeedback: a practitioner's guide 2003, Guilford, New York. ed 3.
2. Davis M, Eshelman ER, McKay M The relaxation and stress reduction workbook 1995, New Harbinger Publications, Oakland, CA. ed 4.
3. Principles and practice of stress management 1993, Guilford, New York. ed 2. P. Lehrer, R.L. Woolfolk (Eds.).
4. Brook RD, Julius S Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 2000, 13:112S-122S.
5. McGrady AV, Higgins JT Prediction of response to biofeedback-assisted relaxation in hypertensives: development of a hypertensive predictor profile (HYPP). Psychosom Med 1989, 51:277-284.
6. Canino E, Cardona R, Monsalve P, et al. A behavioral treatment program as a therapy in the control of primary hypertension. Behavior 1994, 45:23-30.
7. Blanchard EB, McCoy GC, Musso A, et al. A controlled comparison of thermal biofeedback and relaxation training in the treatment of essential hypertension, I: short-term and long-term outcome. Behav Ther 1986, 17:563-579.
8. Blanchard E Biofeedback treatments of essential hypertension. Biofeedback and Self Regulation 1990, 15:209-228.
9. McGrady AV, Linden W Biobehavioral treatments of essential hypertension. Biofeedback: a practitioner's guide 2003, 382-408. Guilford, New York. ed 3. M. Schwartz, F. Andrasik (Eds.).
10. Goebel M, Viol GW, Orebaugh C An incremental model to isolate specific effects of behavioral treatments in essential hypertension. Biofeedback and Self Regulation 1993, 18:255-280.
11. Glasgow MS, Engel BT, D'Lugoff BC A controlled study of a standardized behavioral stepped treatment for hypertension. Psychosom Med 1989, 61:10-26.
12. Achmon J, Granek M, Golomb M, Hart J Behavioral treatment of essential hypertension: a comparison between cognitive therapy and biofeedback of heart rate. Psychosom Med 1989, 51:152-164.
13. Rau H, Buhrer M, Weitkunat R Biofeedback of R-Wave-to-Pulse interval normalizes blood pressure. App Phychophy & Biof 2003, 28:37-46.
14. Schneider RH, Staggers F, Alexander CN, et al. A randomized controlled trial of stress reduction for hypertension in older African Americans. Hyperten 1995, 26:820-827.
15. Alexander CN, Schneider RH, Staggers F, et al. Trial of stress reduction for hypertension in older African Americans, II: sex and risk subgroup analysis. Hyperten 1996, 28:228-237.
16. Linden W, Lenz JW, Con AH Individualized stress management for primary hypertension: a randomized trial. Arch Intern Med 2001, 161:1071-1080.
17. Patel C, Marmot M Can general practitioners use training in relaxation and management of stress to reduce mild hypertension?. Brit Med J 1988, 296:12-14.
18. Henderson RJ, Hart MG, Lal SK, Hunyor SN The effect of home training with direct blood pressure biofeedback of hypertensives: a placebo-controlled study. J Hypertens 1998, 16:771-778.
19. Blanchard EB, McCoy GC, McCaffrey RJ, et al. Evaluation of a minimal-therapist-contact thermal biofeedback treatment program for essential hypertension. Biofeedback and Self Regul 1987, 12:93-103.
20. Rosenthal T, Alter A, Peleg E, Gavish B Device-guided breathing exercises reduce blood pressure: ambulatory and home measurements. Am J Hyperten 2001, 14(1):74-76.
21. Schein M, Gavish B, Herz M, et al. Treating hypertension with a device that slows and regularizes breathing: a randomized double-blind controlled study. J Human Hyperten 2001, 15:271-278.
22. Grossman E, Grossman A, Schein MH, et al. Breathing control lowers blood pressure. J Human Hyperten 2001, 15:263-269.
23. Giannattasio C, Failla M, Meles E, et al. Efficacy of self-treatment of hypertension at home with device-guided breathing. Am J Hyperten 2002, 5:186A.
24. McCraty R, Atkinson M, Tomasino D Impact of a workplace stress reduction program on blood pressure and emotional health in hypertensive employees. J Altern Complement Med 2003, 9:355-369.
25. McGrady AV Effects of group relaxation training and thermal biofeedback on blood pressure and related psychophysiological variables in essential hypertension. Biofeedback and Self-Regul 1994, 19:51-66.
26. Paran E, Amir M, Yaniv N Evaluating the response of mild hypertensives to biofeedback-assisted relaxation using a mental stress test. J Behav Ther & Exp Psychiat 1996, 27(2):157-167.
27. McCubbin JA, Wilson JF Relaxation training and opioid inhibition of blood pressure response to stress. J Consult and Clin Psychol 1996, 64:593-601.
28. Blumental JA, Sherwood A, Gullette ECD, et al. Biobehavioral approaches to the treatment of essential hypertension. J Consult & Clin Psychol 2002, 70:569-589.
29. Spence JD, et al. Recommendations on stress management. JAMC 1999, 160(9 Suppl.):S46-S50.
30. Linden W, Chambers L Clinical effectiveness of non-drug treatment for hypertension: a metaanalysis. Ann Behav Med 1994, 16:35-45.
31. Yucha CB, Clark L, Smith M, et al. The effect of biofeedback in hypertension. Appl Nurs Res 2001, 14:29-35.
32. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart disease. Lancet 1990, 335:827-838.
33. Nakao M, Nomura S, Shimosawa T, et al. Blood pressure biofeedback treatment of whitecoat hypertension. J Psychosom Res 2000, 48:161-169.
34. Grubb BP, Olshansky B Syncope: overview and approach to management. Syncope: mechanisms and management 1998, Futura Publishing, Armonk, NY. B.P. Grubb, B. Olshansky (Eds.).
35. Grubb BP, Karas B Clinical disorders of the autonomic nervous system associated with orthostatic intolerance: an overview of classification, clinical evaluation, and management. PACE 1999, 22:798-810.
36. Kanjwal Y, Kosinski D, Grubb BP The postural orthostatic tachycardia syndrome: definitions, diagnosis and management. PACE 2003, 26:1747-1757.
37. Cohen TJ, Thayapran N, Ibrahim B, et al. An association between anxiety and neurocardiogenic syncope during head-up tilt table testing. PACE 2000, 23:837-841.
38. Dahllöf O, Lars-Göran O The diphasic reaction in blood phobic situations: individually or stimulus bound?. Scand J Behav Ther 1998, 27:97-104.
39. Evans JM, Leonelli FM, Ziegler MG, et al. Epinephrine, vasodilation and hemoconcentration in syncopal, healthy men and women. Auton Neurosci 2001, 93:79-90.
40. Koenig D, Linzer M, Pontinen M, Divine GW Syncope in young adults: evidence for a combined medical and psychiatric approach. J Intern Med 1991, 232:169-176.
41. McGrady A, Kern-Buell C, Bush E, Khuder S, Grubb BP Psychological and physiological factors associated with tilt table testing for neurally mediated syncopal syndromes. PACE 2001, 24:296-301.
42. McGrady AV, Bush EG, Grubb BP Outcome of biofeedback-assisted relaxation for neurocardiogenic syncope and headache: a clinical replication series. Appl Psychophysiol Biofeedback 1997, 22:63-72.
43. McGrady AV, Kern-Buell C, Bush E, et al. Biofeedback-assisted relaxation therapy in neurocardiogenic syncope: a pilot study. Appl Psychophy & Biof 2003, 28:183-192.
44. Girolamo ED, Di Iorio C, Leonzio L, et al. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: a controlled study. Circulation 1999, 100:1798-1801.
45. Krediet CT, van Dijk N, Linzer M, et al. Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 2002, 106:1684-1689.
46. Cowlings PS, Toscano MA, Miller NE, et al. Autogenic-feedback training: a potential treatment for orthostatic intolerance in aerospace crews. Pharmacol 1994, 34:599-608.
47. Gullette EC, Blumenthal JA, Babyak M, et al. Effects of mental stress on myocardial ischemia during daily life. JAMA 1997, 277:1521-1526.
48. Frasure-Smith N, Lesperance F, Talajic M The impact of negative emotions on prognosis following myocardial infarction: is it more than depression?. Health Psychol 1995, 14:388-398.
49. Khawaja IS, Feinstein RE Cardiovascular effects of selective serotonin reuptake inhibitors and other novel antidepressants. Heart Dis 2003, 5:153-160.
50. Everson SA, Kauhanen J, Kaplan GA, et al. Hostility and increased risk of mortality and acute myocardial infarction. Am J Epidemiol 1997, 146:142-152.
51. Buselli EF, Stuart EM Influence of psychosocial factors and biopsychosocial interventions on outcomes after myocardial infarction. J Cardiovasc Nurs 1999, 13:60-72.
52. Turner L, Linden W, van der Wal R, Schamberger W Stress management for patients with heart disease: a pilot study. Heart and Lung 1995, 24:145-153.
53. Gatchel RJ, Gaffney FA, Smith JE Comparative efficacy of behavioral stress management versus propranolol in reducing psychophysiological reactivity in post-myocardial infarction patients. J Behav Med 1986, 9:503-513.
54. Sullivan GM, Kent JM, Coplan JD The neurobiology of stress and anxiety. The management of stress and anxiety in medical disorders 2000, Allyn Bacon, Boston. D.I. Mostofsky, D.H. Barlow (Eds.).
55. Song HS, Lehrer PM The effects of specific respiratory rates on heart rate and heart rate variability. Applied Psychophy Biof 2003, 28:13-23.
56. Bhat N, Bhat K Coronary disease and congestive heart disorder. Handbook of mind-body medicine for primary care 2003, Sage Publications, Thousand Oaks, Ca. D. Moss, A. McGrady, T.C. Davies, I. Wickramasekera (Eds.).
57. Van Dixhoorn J Cardiorespiratory effects of breathing and relaxation instruction in myocardial infarction patients. Biol Psychology 1998, 49:123-135.
58. Moser DK, Dracup K, Woo MA, Stevenson LW Voluntary control of vascular tone by using skin-temperature biofeedback-relaxation in patients with advanced heart failure. Alter Ther Health Med 1997, 3:51-59.
59. Cunningham C, Brown S, Kaski JC Effects of transcendental meditation on symptoms and electrocardiographic changes in patients with cardiac syndrome X. Am J Cardiol 2000, 85:653-655.
60. Zamarra JW, Schneider RH, Besseghini I, et al. Usefulness of the transcendental meditation program in the treatment of patients with coronary artery disease. Am J Cardiol 1996, 77:867-870.
61. Castillo-Richmond A, Schneider RH, Alexander CN, et al. Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans. Stroke 2000, 31:568-573.
62. Linden W Psychological treatments in cardiac rehabilitation: review of rationales and outcomes. J Psychosom Res 2000, 48:443-454.
63. Freedman RR, Ianni P, Wenig P Behavioral Treatment of Raynaud's disease. J Consult Clin Psych 1983, 51:539-549.
64. Freedman RR, Ianni P, Wenig P Behavioral treatment of Raynaud's disease: long-term follow-up. J Consult Clin Psych 1985, 53:136.
65. Raynaud's Treatment Study (RTS) Investigators: Comparison of sustained release nifedipine and temperature biofeedback for primary Raynaud's phenomenon: results from a randomized clinical trial with one year follow-up. Arch Intern Med 2000, 160:1101-1108.
66. Middaugh S, Haythornthwaite JA, Thompson B, Hill R, et al. The Raynaud's treatment study: biofeedback protocols and acquisition of temperature biofeedback skills. Applied Psycho Biofeed 2001, 26:251-278.